Premium
Malignancies requiring temporal bone resection: An Australian single‐institution experience
Author(s) -
Schachtel Michael J. C.,
Gandhi Mitesh,
Bowman James J.,
Erian Christopher,
Porceddu Sandro V.,
Panizza Benedict J.
Publication year - 2021
Publication title -
anz journal of surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.426
H-Index - 70
eISSN - 1445-2197
pISSN - 1445-1433
DOI - 10.1111/ans.16931
Subject(s) - medicine , malignancy , temporal bone , cancer , retrospective cohort study , skull , surgery
Background Malignancies in and around the temporal bone are aggressive and difficult to manage. In Queensland (Australia), where skin cancer rates are exceedingly high, tumours extending to the temporal bone from surrounding structures occur more commonly than primary cancers. Yet, a paucity of evidence exists as to their management and outcomes. This study aimed to review an Australian centre's experience of managing temporal and peritemporal bone malignancies, reporting on patient and tumour characteristics, treatment, and survival outcomes. Methods Retrospective analysis of patients with primary temporal bone cancer and cancers extending to the temporal bone managed by the Queensland Skull Base Unit (Princess Alexandra Hospital) between 2000 and 2019. Results A total of 222 patients were identified, of which 203 (91.4%) had cutaneous primaries, with 167 (75.2%) being squamous cell carcinoma (SCC). 73.9% presented with locoregionally recurrent or residual disease. Secondary tumours (92.8%) were 12 times more frequent than primary malignancies (7.2%), with the preauricular subsite the most common (45.5%). In the 201 patients (90.5%) who underwent curative intent surgery, 5‐year overall survival, disease‐free survival (DFS), and disease‐specific survival was 46.6%, 52.2%, and 65.9%, respectively. The preauricular subsite ( p = 0.004), melanoma (vs. SCC, p = 0.027), involved margins ( p < 0.001), and pathologically involved nodes ( p < 0.001) were associated with significantly worse DFS. Conclusion This is one of the largest studies of temporal bone malignancy in the literature, comprised primarily of secondary cutaneous malignancies. Although clear differences in epidemiological characteristics exist around the world, survival remains poor. Treatment should focus on achieving a clear margin of resection to optimize outcomes.